...
首页> 外文期刊>International journal for numerical methods in biomedical engineering >An adaptive technique based blood glucose control in type-1 diabetes mellitus patients
【24h】

An adaptive technique based blood glucose control in type-1 diabetes mellitus patients

机译:1型糖尿病患者血糖对照的自适应技术

获取原文
获取原文并翻译 | 示例
           

摘要

This study proposes Grasshopper Optimization Algorithm (GOA) based type 1 diabetes mellitus system utilizing the nonlinear Bergman minimal model with proportional integral derivative (PID) controller. GOA is the optimization algorithm, which is utilized for selecting the optimized tuning parameters of the PID controller also solves the nonlinear system parameter identification problem. The novelty of the proposed study is to stabilize the glucose level in blood for type 1 diabetic patients by infusion of insulin in reduced time with optimal quantity. Without any intervention to the normal activities of patients, the supply of insulin injection and glucose monitoring is performed automatically for type 1 diabetic patients using this controller. In between the measured variable and set point, the difference is calculated by the PID controller to evaluate an error values. In realistic patient oriented conditions, the control performance evaluation, control optimization, and advanced patient modelling should be highly concentrated during the research/analysis on blood glucose control. Evaluation is performed to analyze control performances and implementation is done on Simulink/MATLAB environment. The performance analysis of the type 1 diabetes mellitus system with GOA technique is also discussed and to improve the control performance, to optimize the controller parameters. The simulation results have proved the substantial improvement in the performance of proposed algorithm with the better results achieved than the other conventional controllers such as PSO-PID and EHO-PID.
机译:本研究提出了利用具有比例积分衍生(PID)控制器的非线性Bergman最小模型的非线性Bergman最小模型的基于蚱蜢优化算法(GOA)型糖尿病系统。 GOA是优化算法,用于选择PID控制器的优化调谐参数还解决了非线性系统参数识别问题。提出的研究的新颖性是通过在最佳时间减少的时间内输注胰岛素来稳定1型糖尿病患者的血液中的血糖水平。没有任何干预患者的正常活动,使用该控制器自动为1型糖尿病患者自动进行胰岛素注射和葡萄糖监测。在测量的变量和设定点之间,PID控制器计算差异以评估错误值。在现实的患者导向条件下,在血糖控制的研究/分析期间,应高度集中控制性能评估,控制优化和先进的患者建模。进行评估以分析控制性能,在Simulink / Matlab环境下完成实现。还讨论了具有GOA技术的1型糖尿病MELLITUS系统的性能分析,并提高控制性能,优化控制器参数。仿真结果证明了所提出的算法性能的显着提高,其结果比其他传统控制器(如PSO-PID和EHO-PID)为实现的更好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号